Travel Medicine Advisor Archives – January 1, 2006
January 1, 2006
View Archives Issues
-
Updated Guidelines Issued for Occupational PEP Use
The US Public Health Service has changed its treatment guidelines for the use of postexposure prophylaxis (PEP), following an occupational exposure to HIV infection. -
HIV Pill Reminder Device Shows Some Adherence Improvement
Researchers studying a population of HIV patients found that a pill reminder improved adherence for those who were memory impaired. -
Here’s a Nutshell Look at US HIV Preventive Service Task Force Recommendations
The US Preventive Services Task Force recommends that clinicians screen all pregnant women for HIV infection, as well as continue to screen all adolescents and adults who are at increased risk for infection. -
Roche is Under Pressure Over Its Antiviral Drug Tamiflu
Roche, the manufacturer of Oseltamivir (Tamiflu), has found itself struggling to keep up with demand for its antiviral drug in the face of a possible avian flu epidemic. Countries worldwide are stockpiling the drug, which has resulted in hundreds of millions of dollars in sales for the company. -
Drug Resistance Found in SE Area, Representing Poor, Rural Population
A recent study about HIV drug resistance among untreated HIV patients highlights the growing problem of resistance in a Southeastern region of the country. -
Pharmacology Watch: FDA Recommends Approval of Muraglitazar, But May Need To Reconsider
Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions